New research studies surrounding this compound, specifically the high-dose formulation referred to as ZPHC, suggest a considerable impact on body mass decrease and associated health factors. Researchers believe that this innovative compound, targeting both GLP-1 and GIP pathways , could offer a noteworthy improvement in the management of obesit… Read More